We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Antipsychotics and Metabolic Syndrome

This study has suspended participant recruitment.
(this study has not finding place)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00636753
First Posted: March 14, 2008
Last Update Posted: July 30, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Glostrup University Hospital, Copenhagen
March 7, 2008
March 14, 2008
July 30, 2010
September 2008
July 2009   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00636753 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Antipsychotics and Metabolic Syndrome
Not Provided
The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   None Retained
Description:
whole blood, serum/plasma
Probability Sample
patients with debut of schizophrenia, controls from database
Metabolic Syndrome
Not Provided
  • 1
    schizophrenic patients
  • 2
    controls
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
60
Not Provided
July 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Gender male
  • Age 18-45
  • Debut drug-naive schizophrenics,
  • Caucasians
  • Consent given to take part in the project

Exclusion Criteria:

  • Compliance-problems
  • Major lung-/kidney/hart/lever disorders
  • Abuse of alcohol/drugs
  • Diabetes 1 and 2
  • Antihypertensive
  • Anticholesterol-reducing medication
  • Patients under duress
Sexes Eligible for Study: Male
18 Years to 45 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00636753
HC-2007-0070
Yes
Not Provided
Not Provided
dr.med., centerchef Henrik Lublin, Psychiatric Center Glostrup
Glostrup University Hospital, Copenhagen
Not Provided
Not Provided
Glostrup University Hospital, Copenhagen
July 2010